All SEC Filings :: Maravai LifeSciences Holdings, Inc. (MRVI)

Filing Type:

Year:

Date	Form	Description	PDF	XBRL	Pages
04/05/21		Current report filing Documentsexpand_more EX-99.1			7
04/05/21		A correspondence can be sent as a document with another submission type or can be sent as a separate submission.			2
04/05/21		A correspondence can be sent as a document with another submission type or can be sent as a separate submission.			2
04/05/21		General form of registration statement for all companies including face-amount certificate companies Documentsexpand_more EX-5.1 EX-23.1			87
04/01/21		SEC-generated letter Documentsexpand_more TEXT-EXTRACT			1
03/25/21		Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy			80
03/22/21		Annual report pursuant to Section 13 and 15(d) Documentsexpand_more EX-4.2 EX-21.1 EX-23.1 EX-31.1 EX-31.2 EX-32.1 EX-32.2			163
03/02/21		Current report filing Documentsexpand_more EX-99.1			12
02/16/21		Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions			4
02/11/21		Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Documentsexpand_more EX-99.A			19

rss_feed Filing RSS